降钙素
五胃泌素
医学
髓样癌
激素原
内科学
免疫放射分析
恶性肿瘤
内分泌学
降钙素原
甲状腺癌
甲状腺
甲状腺髓样癌
激素
放射免疫分析
胃肠病学
败血症
胃酸
分泌物
作者
H. Bihan,KennethL. Becker,Richard H. Snider,Eric Nylen,L. Vittaz,Céline Lauret,E Modigliani,J Moretti,R. Cohen
出处
期刊:Thyroid
[Mary Ann Liebert]
日期:2003-08-01
卷期号:13 (8): 819-822
被引量:48
标识
DOI:10.1089/105072503768499716
摘要
The hormonal serum marker for the presence and course of patients with medullary thyroid cancer (MTC) is the mature calcitonin (CT) peptide. Other CALC-1 gene products such as the 116-amino acid polypeptide prohormone, procalcitonin, as well as its component calcitonin precursors (CTpr) may also be increased in their sera. We performed a study to evaluate the clinical utility of serum levels CTpr in these patients.Twenty-one patients with MTC (9 males, 12 females; 23-76 years of age) were evaluated. The diagnosis was confirmed by histologic examination, except for 2 (a proven RET mutation plus an abnormal pentagastrin-stimulated CT level). Nine patients had postoperative hypercalcitoninemia and 3 of these died. The specific assay for mature CT was a commercial immunoradiometric assay (hCT-IRMA); the immunoluminometric assay for CTpr (B.R.A.H.M.S Diagnostica, Berlin, Germany) detects intact procalcitonin and the free CT:CT carboxypeptide-1.All patients had detectable serum CTpr. These levels considerably exceeded those of mature CT, averaging 7.6-fold greater. CTpr levels correlated positively with mature CT (r = 0.61; p < 0.001). After pentagastrin administration, there was a parallelism of response between the two assays. Whenever there were known metastases, CTpr increased markedly.This study demonstrates the universal presence of CTpr in the blood of patients with MTC. The measurement of these peptides may offer a new dimension to the clinical evaluation of this malignancy.
科研通智能强力驱动
Strongly Powered by AbleSci AI